Oat agriculture, cultivation and breeding targets: implications for human nutrition and health.
Derek Stewart, Gordon McDougall
https://pubmed.ncbi.nlm.nih.gov/25267245/Actively Recruiting
Led by Standard Process Inc. · Updated on 2026-01-28
38
Participants Needed
1
Research Sites
11 weeks
Total Duration
Researchers are evaluating the effects of high avenanthramide ancient oat Royal Ancient Oats17 muffins compared to conventional oat muffins on blood sugar control and related metabolic factors. This randomized, two-period crossover trial includes 38 non-diabetic adults aged 35 to 65 years who are overweight or obese. The study aims to detect differences in post-meal blood sugar response between the two muffin types and white wheat flour muffins. Participants will first consume white wheat flour muffins for three days to establish a baseline. Then, they will be randomly assigned to receive either Royal Ancient Oats17 muffins or conventional oat muffins in different orders during the two study periods. This crossover design allows each participant to experience both muffin types. The study treatments are provided as dietary supplements in muffin form. Throughout the 2-week study, participants will be monitored for their blood sugar response after eating the muffins, as well as for hormone levels related to digestion and feelings of fullness. The research includes repeated measurements and assessments of metabolic parameters. Participants will follow study procedures carefully, limit intake of certain fiber-rich and high-carbohydrate foods, and avoid supplements or medications that could affect blood sugar. The sponsor is Standard Process Inc.
CONDITIONS
Royal Ancient Oats™ Study
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Standard Process Inc.
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Muffin with Royal Ancient Oat Flour™ | Muffin with Conventional Oats or White Wheat Flour |
|---|---|---|
| What it is | Participants receive muffins specifically formulated with Royal Ancient Oat Flour™, a type of oat rich in avenanthramides, a class of bioactive phytochemicals. | Participants receive control muffins made with either conventional oat flour or standard white wheat flour, representing typical bakery ingredients. |
| Role in trial | This is the investigational condition examined to assess its effects on post-meal blood glucose and hormone responses. | This control condition serves as a comparator to evaluate changes caused by the Royal Ancient Oat Flour™ muffin, using conventional flour as a standard. |
| Primary use | Evaluated as a dietary supplement to examine its impact on immediate blood glucose changes and hormone levels after eating. | Used as the comparison food to establish baseline and contrast the effect of Royal Ancient Oat Flour™ on glucose and hormone outcomes. |
| How it is given or performed | Participants eat study-provided muffins containing Royal Ancient Oat Flour™. Each participant completes both study conditions in a specific randomized order. | Participants eat control muffins made with conventional oat or white wheat flour, receiving them in a different order than the test muffins. |
| Evidence status | Oat-derived avenanthramides are under investigation for effects on blood sugar and satiety hormones. Past studies show that oats containing avenanthramides can inhibit intestinal glucose absorption, but this specific formulation's effect in this population is still under study. | White wheat flour and conventional oat flour are common control foods used to study comparative effects of higher-fiber oats. They do not contain elevated avenanthramide concentrations as found in Royal Ancient Oats™. |
| Important limitations | The trial is limited to non-diabetic adults with overweight, so findings may not be generalizable to the broader population. The effects on people with diabetes or different age/BMI profiles remain unknown. | This comparator does not capture effects relative to other whole grains, fruits, or diets. Response to white wheat or conventional oat flour may differ in those with chronic conditions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 days
Participants consume white wheat flour muffins for three consecutive days to establish a baseline for comparison.
Daily visits or assessments for 3 days
Duration - 2 weeks
Participants consume Royal Ancient Oats™ muffins and conventional oat muffins in a randomized order to evaluate effects on glycemic response and metabolic parameters.
Multiple visits during the 2-week treatment periods
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Derek Stewart, Gordon McDougall
https://pubmed.ncbi.nlm.nih.gov/25267245/Haonan Zhouyao, Lovemore Nkhata Malunga, Yi Fang Chu...
https://pubmed.ncbi.nlm.nih.gov/35892210/Faina Wehrli, Petek E Taneri, Arjola Bano...
https://pubmed.ncbi.nlm.nih.gov/34444718/Amna Shehzad, Roshina Rabail, Seemal Munir...
https://pubmed.ncbi.nlm.nih.gov/36790719/Peter Francis Raguindin, Oche Adam Itodo, Jivko Stoyanov...
https://pubmed.ncbi.nlm.nih.gov/32950005/C-Y Oliver Chen, Paul E Milbury, F William Collins...
https://pubmed.ncbi.nlm.nih.gov/17513394/Erand Llanaj, Gordana M Dejanovic, Ezra Valido...
https://pubmed.ncbi.nlm.nih.gov/34977959/Shengmin Sang, YiFang Chu
https://pubmed.ncbi.nlm.nih.gov/28067025/Standard Process Inc.
Lead Sponsor